Q2i’s reward-based digital technology moves to Phase II of National Institutes of Health (NIH) clinical trial to further evaluate the application’s efficacy in increasing treatment adherence for substance use disorder after an ED Visit
July 20th, 2021 | 🕒
iSpeech BOSTON, July 20, 2021 /PRNewswire/ -- Q2i, a provider of digital health technology, announced today that they have been granted
Gloss